The annual Genesis conference has been a pillar of the Life Science sector for over two decades. Bringing together key opinion leaders, investors, and innovators from across the sector to share insight, debate key trends and generate deals.
Attending the Genesis in-person meeting is PrecisionLife Co-founder Rowan Gardner. During the event, Rowan will join an experienced group of experts a panel session.
Panel: Is Technology Diversifying Biomedical R&D Outputs?
Time: 13:30 - 14:30
Summary: The ability to generate, collect and analyze data from diverse sources has never advanced more rapidly. The panel will discuss whether this is leading to greater diversity in areas such as, target selection & drug design, patient stratification in clinical trials, scale of collaboration and skills.
Moderator: Lisa Melton, Nature Biotechnology
Panelists:
For more information, visit the Genesis website.